Johnson & Johnson Expands Tylenol Arthritis Recall (JNJ)

Dec 29, 2009 (SmarTrend(R) News Watch via COMTEX) -- JNJ | Quote | Chart | News | PowerRating -- 12/29/2009-Johnson & Johnson (NYSE:JNJ) is now recalling all product lots of the Arthritis Pain Caplet 100 count bottles with the red EZ-Open Cap, according to a statement on the Food and Drug Administration website.

The recall was due to a moldy odor that can cause nausea and stomach pain caused by trace amounts of the chemical 2, 4, 6-tribromoanisole resulting from the breakdown of another chemical used to treat wooden pallets.

Side effects also include vomiting

and diarrhea, but have been "temporary and non-serious."

All Tylenol Arthritis products, other than the lots specified, remain available.

Shares of Johnson & Johnson are unaffected in premarket trading on the news.

Write to Chip Brian at cbrian@tradethetrend.com

SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html

For full details on Johnson & Johnson (JNJ) click here. Johnson & Johnson (JNJ) has Short Term PowerRatings of 5. Details on Johnson & Johnson (JNJ) Short Term PowerRatings is available at This Link.